Lawrence Blatt

Chief Executive Officer at Aligos Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Aligos Therapeutics Inc., 2 years.

Aligos Therapeutics Inc. Director · President and CEO
2 years · Since 2023

Chief executive roles

Aligos Therapeutics Inc. · Chief Executive Officer
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 25, 2023 Aligos Therapeutics Inc. Grant or award +610,277 $0.76 $463,811

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.